Citigroup »

Intellia Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 168k 30.49
2023-09-30 $8.6M 271k 31.62
2023-03-31 $5.8M 156k 37.30
2022-12-31 $3.5M 99k 34.89
2022-09-30 $9.4M 167k 56.60
2021-12-31 $7.8M 66k 118.34
2021-03-31 $5.9M 74k 80.00
2020-12-31 $888k 16k 55.73
2020-09-30 $473k 26k 18.58
2020-06-30 $883k 41k 21.67
2020-03-31 $640k 52k 12.23
2019-12-31 $1.4M 95k 14.69
2019-09-30 $1.7M 128k 13.40
2019-06-30 $1.1M 68k 16.37
2019-03-31 $674k 40k 16.99
2018-12-31 $3.9M 287k 13.74
2018-09-30 $5.1M 178k 28.58
2018-06-30 $3.3M 121k 27.35
2018-03-31 $1.2M 56k 21.13
2017-12-31 $940k 49k 19.22
2017-06-30 $2.0k 152 13.16
2017-03-31 $999 71 14.08
2016-12-31 $0 5 0.00
2016-09-30 $10k 573 17.45
2016-06-30 $15k 703 21.34